Literature DB >> 12002648

Erythromycin resistance in italian isolates of Streptococcus pyogenes and correlations with pulsed-field gel electrophoresis analysis.

Claudia Zampaloni1, Luca A Vitali, Manuela Prenna, Maria A Toscano, Gianna Tempera, Sandro Ripa.   

Abstract

Erythromycin resistance among Streptococcus pyogenes strains has been reported in Italy at high rates during the last few years. A total of 152 erythromycin-resistant isolates of this species from southern Italian regions were characterized for the macrolide-resistance phenotype and screened by PCR for the corresponding genetic determinant. A close correlation was found between these phenotypic/genotypic data concerning macrolide resistance and results of Sma I macrorestriction fragment patterns (PFGE) analysis. In fact, the vast majority of the isolates assigned to individual PFGE classes mostly belonged to a single phenotype of macrolide resistance. All untypeable isolates belonged to the M phenotype. Twenty-two distinct PFGE types were recognized, of which 11 were recorded in only one isolate (one-strain type); about 50% of typeable isolates fell into five type clusters and 70% in seven. The increased erythromycin resistance among Italian isolates of S. pyogenes does not appear to be due to the spread of a single clone, but results indicate that the majority of group A streptococci examined are probably spread from a limited number of clones.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12002648     DOI: 10.1089/10766290252913746

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

1.  Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.

Authors:  Young Uh; In Ho Jang; Gyu Yel Hwang; Mi Kyung Lee; Kap Jun Yoon; Hyo Youl Kim
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

2.  emm Gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes.

Authors:  Claudia Zampaloni; Paola Cappelletti; Manuela Prenna; Luca Agostino Vitali; Sandro Ripa
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy.

Authors:  D Petrelli; M C Di Luca; M Prenna; P Bernaschi; A Repetto; L A Vitali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-05       Impact factor: 3.267

4.  DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci.

Authors:  T A Figueiredo; S I Aguiar; J Melo-Cristino; M Ramirez
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

5.  Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001.

Authors:  Kevin C Katz; Allison J McGeer; Carla L Duncan; Aisha Ashi-Sulaiman; Barbara M Willey; Alicia Sarabia; Jacquie McCann; Sylvia Pong-Porter; Yana Rzayev; Joyce S de Azavedo; Donald E Low
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

6.  Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Chun-Ming Lee; Wen-Kuei Huang; Tsu-Lan Wu; Jen-Hsien Wan; Dine Yang; Jainn-Ming Shyr; Yin-Ching Chuang; Jing-Jou Yan; Jang-Jih Lu; Jiunn-Jong Wu; Wen-Chien Ko; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Hsieh-Shong Leu; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

7.  Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.

Authors:  G Gherardi; D Petrelli; M C Di Luca; F Pimentel de Araujo; P Bernaschi; A Repetto; J Bellesi; L A Vitali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-30       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.